Evommune, Inc. (EVMN)
NYSE: EVMN · Real-Time Price · USD
14.21
+0.14 (1.00%)
At close: Aug 11, 2026, 4:00 PM EDT
14.21
0.00 (0.00%)
After-hours: Aug 11, 2026, 4:10 PM EDT
Evommune Market Cap
Evommune has a market cap or net worth of $515.71 million as of August 11, 2026.
Market Cap
515.71M
Enterprise Value
323.55M
1-Year Change
n/a
Ranking
Category
Stock Price
$14.21
ChartMarket Cap Chart
Since the IPO on November 6, 2025, Evommune's market cap has increased from $481.24M to $515.71M, an increase of 7.16%. That is a compound annual growth rate of 9.51%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2026 | 515.71M | -4.44% |
| Dec 31, 2025 | 539.69M | 12.15% |
| Nov 6, 2025 | 481.24M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Adlai Nortye | 523.40M |
| Eikon Therapeutics | 522.17M |
| Ginkgo Bioworks Holdings | 517.85M |
| Assembly Biosciences | 517.66M |
| ProKidney | 505.95M |
| Entera Bio | 502.11M |
| OmniAb | 497.24M |
| Valneva SE | 496.81M |